Poly Medicure Limited (POLYMED) - Total Assets

Latest as of March 2026: Rs39.19 Billion INR ≈ $423.78 Million USD

Based on the latest financial reports, Poly Medicure Limited (POLYMED) holds total assets worth Rs39.19 Billion INR (≈ $423.78 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check POLYMED cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Poly Medicure Limited - Total Assets Trend (2006–2026)

This chart illustrates how Poly Medicure Limited's total assets have evolved over time, based on quarterly financial data. Explore Poly Medicure Limited long-term investment intensity to see how much of total assets are deployed in long-term investments.

Poly Medicure Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Poly Medicure Limited's total assets of Rs39.19 Billion consist of 49.6% current assets and 50.5% non-current assets.

Asset Category Amount (INR) % of Total Assets
Cash & Equivalents Rs0.00 2.2%
Accounts Receivable Rs5.32 Billion 13.6%
Inventory Rs4.34 Billion 11.1%
Property, Plant & Equipment Rs0.00 0.0%
Intangible Assets Rs1.65 Billion 4.2%
Goodwill Rs2.74 Billion 7.0%

Asset Composition Trend (2006–2026)

This chart illustrates how Poly Medicure Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see POLYMED market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Poly Medicure Limited's current assets represent 49.6% of total assets in 2026, an increase from 34.0% in 2006.
  • Cash Position: Cash and equivalents constituted 2.2% of total assets in 2026, up from 0.4% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 16.0% in 2006.
  • Asset Diversification: The largest asset category is accounts receivable at 13.6% of total assets.

Poly Medicure Limited Competitors by Total Assets

Key competitors of Poly Medicure Limited based on total assets are shown below.

Company Country Total Assets
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
China CN¥12.68 Billion
Andon Health Co Ltd
SHE:002432
China CN¥29.91 Billion
Pegavision
TW:6491
Taiwan NT$16.17 Billion
Tarsons Products Limited
NSE:TARSONS
India Rs11.64 Billion
SciVision Biotech Inc
TW:1786
Taiwan NT$2.67 Billion
Nyxoah
BR:NYXH
Belgium €93.60 Million
I.Ceram SA
PA:ALICR
France €3.91 Million
Ansell Ltd
AU:ANN
Australia AU$3.33 Billion

Poly Medicure Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.37 5.18 4.12
Quick Ratio 2.62 4.41 3.38
Cash Ratio 0.00 0.39 0.00
Working Capital Rs13.66 Billion Rs15.47 Billion Rs5.34 Billion

Poly Medicure Limited - Advanced Valuation Insights

This section examines the relationship between Poly Medicure Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.51
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 22.7%
Total Assets Rs39.19 Billion
Market Capitalization $1.72 Billion USD

Valuation Analysis

Below Book Valuation: The market values Poly Medicure Limited's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Poly Medicure Limited's assets grew by 22.7% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Poly Medicure Limited (2006–2026)

The table below shows the annual total assets of Poly Medicure Limited from 2006 to 2026.

Year Total Assets Change
2026-03-31 Rs39.19 Billion
≈ $423.78 Million
+22.74%
2025-03-31 Rs31.92 Billion
≈ $345.25 Million
+71.76%
2024-03-31 Rs18.59 Billion
≈ $201.01 Million
+17.85%
2023-03-31 Rs15.77 Billion
≈ $170.57 Million
+14.55%
2022-03-31 Rs13.77 Billion
≈ $148.90 Million
+12.51%
2021-03-31 Rs12.24 Billion
≈ $132.34 Million
+59.48%
2020-03-31 Rs7.67 Billion
≈ $82.98 Million
+17.34%
2019-03-31 Rs6.54 Billion
≈ $70.72 Million
+15.78%
2018-03-31 Rs5.65 Billion
≈ $61.08 Million
+24.25%
2017-03-31 Rs4.55 Billion
≈ $49.16 Million
+17.49%
2016-03-31 Rs3.87 Billion
≈ $41.84 Million
+6.29%
2015-03-31 Rs3.64 Billion
≈ $39.37 Million
+27.30%
2014-03-31 Rs2.86 Billion
≈ $30.92 Million
+33.32%
2013-03-31 Rs2.14 Billion
≈ $23.20 Million
+18.01%
2012-03-31 Rs1.82 Billion
≈ $19.66 Million
+18.85%
2011-03-31 Rs1.53 Billion
≈ $16.54 Million
+20.73%
2010-03-31 Rs1.27 Billion
≈ $13.70 Million
+18.91%
2009-03-31 Rs1.07 Billion
≈ $11.52 Million
+9.86%
2008-03-31 Rs969.55 Million
≈ $10.49 Million
+21.44%
2007-03-31 Rs798.41 Million
≈ $8.63 Million
+39.41%
2006-03-31 Rs572.69 Million
≈ $6.19 Million
--

About Poly Medicure Limited

NSE:POLYMED India Medical Instruments & Supplies
Market Cap
$1.72 Billion
Rs159.46 Billion INR
Market Cap Rank
#6810 Global
#309 in India
Share Price
Rs1573.20
Change (1 day)
+2.32%
52-Week Range
Rs1191.10 - Rs2270.00
All Time High
Rs3128.90
About

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; crit… Read more